Cakmak ME, Oztop N, Yegit OO, Ozdedeoglu O, et al. Evaluation of the clinical features and laboratory data of patients with severe asthma classified as super-responder or non super-responder to omalizumab treatment: a single-centre real-life study. J Asthma 2023 Mar 27:1-10. doi: 10.1080/02770903.2023.2196562.
PMID: 36971065